Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Germany”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 541 records · Page 30Linked to original sources

The protection of the person in medical research in Germany.

Because of its history Germany has many rules concerning the protection of persons in medical research. In fact Germany was the first state to issue a directive regulating medical experimentation with human beings in the year 1900. The ten principles of Nuremberg originated out of the medical case. Germany adheres to the Revised Declaration of Helsinki of the World Medical Association and will probably sign the European convention on biomedicine. The pharmaceutical act contains elaborate provisions for the protection of the patient or proband, e.g. informed consent, risk-benefit ratio, no experimentation on prisoners, approval of a local ethics committee. Moreover in pharmaceutical trials there has to be third party accident insurance for the experimental subject. There is no strict liability for medical experimentation, but the standard of care is high. In general the German law seems to be adequate for the protection of experimental subjects.

Confidentiality↗

[The effect of health care reform in Germany on the pharmacist's role in pharmacotherapy].

The present paper describes the pharmacist's role in Germany during the health-service reform and shows his prospects within pharmacological therapy and his role in contemporary modern society. However, emphasis is placed on the out-patient provision of drugs. The development of the recent years clearly indicates the effects of the health-service reform on all concerned in German health services. For this reason the present paper has been extended to include the description of the current social and health guidelines for health services. Moreover, it also describes the individual stages of the health-service reform in Germany between 1989 and 1997. The theoretical part was supported by patient's opinion polls. With examples of 500 interviewees from Bavaria and Baden-Württemberg, patient habits were surveyed regarding drug consumption, compliance, self-treatment, and drug information as well as the patient's expectations of the pharmacist. Depending on the growth of scientific knowledge in health services and on the need for medical care, the pharmacist's role has to undergo continuous changes, worldwide. Due to the analysis and scrutiny of the transformation of German health services--for Germany has a state health insurance in traditional solidarity--the present paper gives a prediction concerning further development, and, above all, the necessary changes in the pharmacist's work in the framework of health services to be carried out. Generally it is possible to say that the obtained knowledge has general validity which other countries can make use of while considering their local conditions.

Drug Therapy↗

Smoking prevalence and lung cancer mortality in Germany.

From investigations of smoking habits, which included information about onset of smoking, we have extrapolated gender- and age-specific smoking prevalence in Germany back to the 1920s. The exploration of these data, together with an analysis of lung cancer mortality by age-period-cohort models shows that the increase of smoking and lung cancer is modulated by factors related to the country-specific socio-economic environment and that it proceeds in waves. Though recent data indicate a decline in the prevalence of smoking among both sexes, Germany is now on the way to having a similar smoking-related cancer mortality to those countries in the world which previously had a much higher rate, but have intervened vigorously. The refusal in Germany to adopt actions such as those successfully implemented to save lives in these countries means that the German population is exposed to avoidable risks, whose effects can be counted in the terms of the thousands of lives that might have been saved each year.

Adolescent↗

[Incidence of allergic diseases in East and West Germany].

Using data of the German National Health Interview and Examination Survey 1998, a remarkable difference in the prevalence of hay fever between East and West Germany has been observed. Several studies in children and adults have also shown a considerable East-West divergence in other allergic diseases and in sensitisation rates. The aim of this investigation was to examine whether in a representative sample of the adult German population East-West differences in the frequency of asthma, atopic dermatitis, food allergy, urticaria, contact dermatitis and "other allergies" can be found. The calculations base on data of a physician's interview in which study participants were asked whether a physician had ever diagnosed one of the above mentioned diseases. A higher prevalence of all allergic diseases has been observed in West compared to East Germany and women from both parts of the country have higher morbidity rates than men. At least one physician-diagnosed allergy was reported by 40% of the study participants, whereas in East Germany about 30% and in the West 43% suffer from an allergic disease. The prevalence in women is 47% and in men 33%. Extremely high allergy rates were found among West German women at the age of 30-39 years (62%). Although the frequency of allergies decreases with increasing age, considerably high morbidity rates were ascertained even in the oldest age groups. The prevalence in participants aged 70-79 years amounts to 25%. Clear differences between East and West could be demonstrated in this age group, too (West 27% and East 14%).

Adolescent↗

[Changes in incidence and prevalence of acute and chronic pancreatitis in Germany].

It is difficult to provide valid data with regard to changes in incidence and prevalence of acute pancreatitis in Germany. The lack of information is due to strict legal regulations to protect personal data, a certain lack of interest in epidemiological research and the lack of exact statistics of diseases treated in hospitals. The incidence of acute pancreatitis in other industrialized Western countries is about 10 new cases per year and 100,000 inhabitants. The increase of alcohol consumption over the last 30 years is associated with an increase of ethanol-induced pancreatitis. One may speculate that due to improved diagnostic possibilities, such as CT scan, cases where acute pancreatitis is diagnosed at autopsy are rare. Due to the increase in alcohol consumption it can be assume that the incidence and prevalence of chronic pancreatitis have increased in Germany similar to well-documented data from Denmark. Since alcohol consumption is slightly decreasing in Germany it is likely that the present incidence of about 10 cases of chronic pancreatitis per 100,000 inhabitants will also decrease.

Acute Disease↗

Tinea capitis in Germany. A survey in 1998.

Under the assignment of the ECMM (European Confederation of Medical Mycology) a survey regarding frequency, infectious spectrum and therapy of tinea capitis was conducted in Germany in 1998. In this survey 154 dermatology practitioners and 19 hospitals throughout Germany participated. There were 394 conditions reported, 377 with and 17 without identification of the infectious agent. The most frequent infectious agent was M. canis (n = 216; 54.8%) before T. mentagrophytes (n = 58; 14.7%), T. verrucosum (n = 32; 8.1%), T. violaceum (n = 24; 6.1%) and T. tonsurans (n = 15; 3.8%). Zoophilic dermatophytes (n = 306; 81.2%) predominated over anthropophilic species (n = 71; 18.8%) in the ratio of 4:1. Tinea capitis microsporica showed to be a more frequent infectious disease again which due to its high virulence and contagiosity of the infectious agent represents a therapeutical problem. Tinea capitis occurred in an average age of 17.3 years. The preferred therapeutical regimen was a combination of systemic and topical antimycotics in 61.5% (n = 176) of the reported cases (n = 286). A solely topical or systemical monotherapy was reported in 25.2% (n = 72) respectively 13.3% (n = 38) of the patients. In case of systemic antimycotics the most frequent used drugs were griseofulvin (43.0%, n = 101), fluconazole (25.1%, n = 59) or itraconazole (18.7%; n = 44), in topical preparations ciclopiroxolamine dominated (53.3%, n = 121) prior to clotrimazole (13.2%, n = 30) and terbinafine (7.1%, n = 16). Different from the situation in Germany and in Southern Europe some of the western European countries show a tendency of an increase of anthropophilic agents in tinea capitis.

Germany↗

Regular dialysis treatment in Germany: the role of non-profit organisations.

Germany's healthcare system is almost entirely premium-funded through compulsory insurance. Doctors practicing in an outpatient setting are obliged to be members of the "Kassenarztliche Vereinigung" (KV), a kind of union for physicians that has to guarantee adequate medical care for all insured patients. Health money is transferred from health insurances to KV and then distributed to individual doctors. In 1998, 47,000 patients were treated in Germany by dialysis, 40% in privately-owned units, 22% in hospital units and 40% by non-profit facilities. Of these, 35% have diabetes mellitus, 50% of the patients new to dialysis. A total of 92% are treated in HD units, 1.5% at home, and 6.7% by PD. Not-for-profit organisations were founded in 1969 to overcome the shortage of dialysis facilities. These organisations provide all the non-medical components of dialysis therapy such as machines, disposables, buildings, employment, and management of staff. Nephrologists who are employed by or work with not-for-profit organisations are free to choose the best medical therapy, with no economic bias. Assessment of dialysis quality is not yet official in Germany and it is not clear whether there are different provider associated outcomes.

Comorbidity↗

[Animal-derived feedstuffs as possible vectors for bovine encephalopathy (BSE) in Germany. Part 2: Assessment of vector risk for compounded feed].

Specific conditions and practices of cattle feeding in Germany have to be taken into account for assessing the risk of feed born transmission of bovine spongiform encephalopathy, especially regarding the situation before the year 2000 when specific directives were introduced for feed production. The present retrospective epidemiological study includes data on feed production and the estimated amount of animal derived feedstuffs for the production of compounded feed for cattle. Risk assessment was performed based on the 'reproduction rate' (R0), that is defined as the estimated number of infections resulting from the processing of brain and spinal cord of BSE affected cattle that is recycled to bovines via feed. Under the conditions as given in Germany until the year 2000 the reproduction rate of BSE via the inclusion of animal derived feedstuffs in compounded feed production for cattle was estimated to be 1.1. Thus, it can be expected that BSE could be reproduced in the system, but with comparatively low efficiency. The expected incidence of BSE should be considerably lower compared to the situation during the 90th in the UK, due to the markedly lower recycling rate of animal protein in cattle feeding. Animal fat could have been a significant factor for BSE transmission due to contamination by proteinaceous brain and spinal cord material during the production process. The relative significance of fat containing feedstuffs for BSE transmission could have been higher in Germany compared to the situation in the UK where meat and bone meal was produced under different conditions and frequently used in higher proportions as an ingredient for compounded feed for ruminants.

Animal Feed↗

[What does the medical student learn in pathology in Germany, China and the USA?].

From the point of view of a medical student who studied at a couple of universities in Germany, one semester at a medical school in the USA, and who was involved in an exchange-program with a Chinese university, the importance of pathology as a main part of the medical course is stressed.--In Germany and the USA, pathology is a central subject in the medical course studies. After studying how the human body functions correctly (anatomy, physiology etc.), the medical student learns the pathological basics of diseases. Then clinical training, including electives or rotations, starts, where the student enters clinical settings and learns how to treat these diseases. As medicine is going to be more and more specialized, this will sooner or later also have consequences on the system of medical teaching. In the USA, for example, it is to a certain extent possible to specialize during clinical rotations already. For this reason, pathology is going to be even more important in the future.--In China there are two medical systems that exist independently: Our so-called Western Medicine and Traditional Chinese Medicine. The biggest difference in traditional medicine seems to be that diseases are treated without any (western) knowledge of their pathological background, but with the empirical knowledge of 5000 years of Chinese Medicine (so-called "black-box-system").--In conclusion, pathology is fundamental to the understanding of diseases in humans in Western Medicine. The facts taught are, of course, the same everywhere. There are differences as far as the teaching methods are concerned, both between the different countries and within Germany. Most important is the attitude of both medical students and teaching staff.

China↗

Incidence and tumour stages of breast cancer in the region of Aachen, Germany.

We present epidemiological data of female breast cancer in the region of Aachen (Germany) including incidence and tumour stages for the period 1996-1997. Furthermore, we compare epidemiological data from Aachen with data from the directly neighbouring Dutch region South-Middle Limburg before and after the introduction of a national mammographic screening programme. The field study of breast cancer was undertaken at the Institute of Pathology and Comprehensive Cancer Center at the University of Aachen, supported by the Federal Ministry of Health (Germany), using data files from the Cancer Registry Aachen. The patient's consent to collect all data concerning her epidemiological and social situation as well as information on the outcome of disease was obtained in 83.4% of all cases. The remaining 16.6% of the cases without a patient's consent are based on histopathological reports. Only those patients are included who were documented as residing in the region of Aachen at the time of diagnosis. Tumour cases were counted according to International Agency for Research on Cancer rules and tumour stages are classified according to UICC guidelines. Incidence rates are calculated as crude value, adapted to the European and World Standard population (ESR, WSR), and the age specific incidence is presented in 5-year intervals. The cumulative risk is assessed for a certain life span by summarizing the age-specific incidences. The age-standardized breast cancer incidence rate in Aachen was 94 per 100 000 women in 1996 and 90 cases of invasive breast cancer per 100 000 women in 1997 according to the ESR. The cumulative risk of developing breast cancer in the life span ranging from 0 to 74 years is approximately 8%. The stage distribution of breast cancer reveals only 4% favourable carcinomata in situ, but 12% advanced T4 tumours. T1 and T2 tumour stages count for about 40% and T3 tumour stages about 4%. Incidence rates and the tumour stages of breast cancer in the region of Aachen during 1996 and 1997 are similar to the data obtained from the directly neighbouring Cancer Center of the region South-Middle Limburg, in the Netherlands, in 1989/1990 before the beginning of the national breast cancer screening programme. However, major differences are found in terms of the incidence and the tumour stages between Aachen 1996/1997 and South-Middle Limburg 1995/1996 after the introduction of the mammographic screening. The incidence of female breast cancer in Aachen, Germany, was high and in the range of the data from other cancer registries in Europe without national screening programmes. The tumour stages at diagnosis in Aachen were not very favourable, especially in elderly women. An increase of the cancer incidence and a shift of the tumour stages to more favourable ones were observed in the neighbouring Dutch region of South-Middle Limburg, comparing data from 1989/90 and 1995/96. This is probably as a result of the national mammographic screening programme. As data from Aachen were similar to Limburg's data from 1989/90 before the mammographic screening was introduced, it will be important to follow and compare the cancer incidence and the tumour stages in the future.

Breast Neoplasms↗

Migration and ethnicity in a non-immigration country: foreigners in a united Germany.

"The re-unification of Germany has dramatically altered the position of settled minorities in [the former West Germany]. Ethnic Germans have been granted rights hitherto denied to migrant workers and their descendants. There has been a pronounced growth in hostility and violence directed mainly at Turks and Yugoslavs. This has been most evident amongst the former citizens of the [former East Germany] and other ethnic Germans. These events have posed anew questions of legitimacy which have been answered so far in terms reminiscent of ideologies from the Second World War."

Culture↗

Immigration to the Federal Republic of Germany as a demographic and social problem.

"Addressing the question of immigration to Western Europe and especially to Germany from east and southeast Europe and from developing countries of the South, this article considers whether such immigration can compensate for reductions in population in developed countries. It is argued that the demographic deficits of an aging population can only be corrected to a limited extent through immigration. Any solution, in order to be effective, must include a simultaneous increase in the birthrates of Germany and other European Community countries. With particular regard to future social development in Germany and the EC, it would be advisable for governments to effect measures that will provide both for controlled admissions of immigrants from outside the EC and an increase in local reproductive capabilities."

Demography↗

Impact of migration on Helicobacter pylori seroprevalence in the offspring of Turkish immigrants in Germany.

Helicobacter pylori (H. pylori) infection rates differ markedly between distinct populations. Consistent with previous findings of high seroprevalences in less developed countries, Turkish people have been reported to constitute a high-risk population. H. pylori prevalence rates have tended to be lower in Turkish individuals living in Germany for more than one generation. We conducted a seroepidemiological study to determine the impact of ethnicity, environmental setting, and sociodemographic factors on H. pylori seropositivity. Three subgroups were recruited encompassing 675 Germans (402 males, 273 females), 260 Turkish people born and raised in Germany (145 males, 115 females) and 148 Turkish people living in Turkey (91 males, 57 females), Ages ranged from newborn to a maximum of 30 years in all subgroups. H. pylori immunoglobulin G serum antibodies were determined by a commercial ELISA. H. pylori age-adjusted overall seroprevalence clearly differed between Germans (13.1%) and Turkish subgroups, with prevalences of 30.4% (Turks in Germany) and 44.5% (Turks in Turkey) seropositive individuals (p<0.001). Infection occurred at a younger age in Turks independent of country. Besides age, ethnicity was the only independent and significant predictor of H. pylori seropositivity using multiple logistic regression analysis (odds ratio 2.5; 1.3-5.0 95% confidence interval CI). Place of residence and number of children tended to influence H. pylori seroprevalence but without achieving statistical significance. Our data suggest that high H. pylori seroprevalence in Turkish people depends on factors that are only insignificantly influenced by migration. The causal environmental factors within this cohort and/or sociocultural practices that perpetuate and encourage the spread of infection remain to be identified.

Adolescent↗

Prevalence of sexual abuse of children in Germany.

A survey of the prevalence of sexual abuse of children in two different areas of Germany (Würzburg - former West Germany and Leipzig - former East Germany) was conducted using a multiple screen questionnaire. The sample consisted of 1841 students from different institutions in Würzburg and 310 students from vocational schools in Leipzig (n = 2151). Data on a similar number of males and females were recorded. Problems of definition, sample characteristics and methodology are discussed. Sexual abuse was reported by 16.1% of the women and 5.8% of the men in the Würzburg sample and 9.6% and 5.8%, respectively, in the Leipzig sample. More comparable subsamples showed less discrepancy in the prevalence rates for women in the two cities.

Adolescent↗

Varroa-tolerant Italian honey bees introduced from Brazil were not more efficient in defending themselves against the mite Varroa destructor than Carniolan bees in Germany.

In Europe and North America honey bees cannot be kept without chemical treatments against Varroa destructor. Nevertheless, in Brazil an isolated population of Italian honey bees has been kept on an island since 1984 without treatment against this mite. The infestation rates in these colonies have decreased over the years. We looked for possible varroa-tolerance factors in six Italian honey bee colonies prepared with queens from this Brazilian island population, compared to six Carniolan colonies, both tested at the same site in Germany. One such factor was the percentage of damaged mites in the colony debris, which has been reported as an indicator of colony tolerance to varroa. A mean of 35.8% of the varroa mites collected from the bottoms of the Italian bee colonies were found damaged, among which 19.1% were still alive. A significantly greater proportion of damaged mites were found in the Carniolan bees (42.3%) and 22.5% were collected alive. The most frequent kind of damage found was damaged legs alone, affecting 47.4% of the mites collected from debris in Italian bees, which was similar to the amount found in Carniolan colonies (46%). The mean infestation rate by the varroa mite in the worker brood cells in the Italian bee colonies was 3.9% in June and 3.5% in July, and in drone brood cells it was 19.3% in June. In the Carniolan honey bee colonies the mean infestation rates in worker brood cells were 3.0 and 6.7%, respectively in the months of June and July and 19.7% in drone brood cells in June. In conclusion, the 'Varroa-tolerant' Italian honey bees introduced from Brazil produced lower percentages of damaged mites (Varroa destructor) in hive debris and had similar brood infestation rates when compared to 'susceptible' Carniolan bees in Germany. In spite of the apparent adaptation of this population of Italian bees in Brazil, we found no indication of superiority of these bees when we examined the proportions of damaged mites and the varroa-infestation rates, compared to Carniloan bees kept in the same apiary in Germany.

Animals↗

[An assessment of patient education programmes for patients with type 1 and 2 diabetes, asthma and COPD, coronary heart disease, hypertension, congestive heart failure, and breast cancer in Germany].

BACKGROUND: Patient education programmes will be a mandatory part of the new legislation on disease management programmes for chronic diseases in Germany. Today, only little is known about the number, variety and effectiveness of implemented patient education programmes in Germany. METHODS: 176 potential providers of patient education programmes were identified by literature search, Internet search, and interviews with health education experts. We developed a semi-structured questionnaire. Assessment of content and quality was conducted in two steps by using defined criteria of the Co-ordinating Committee, the Head Association of the statutory health insurances and the respective Medical Associations: the first step was to check whether the programme had a structured teaching concept and whether all requirements for education with respect to a given disease had been taken into account. In the second step, we used balance sheets for reviewing the strengths and weaknesses of the programmes. RESULTS: 49 providers handed in 95 pa tient education programmes for assess ment. Due to formal mistakes only 91 programmes could be analysed. 49 programmes failed the criteria of the first assessment step. For the remaining 42 patient education programmes balance sheets were prepared. Areas of the most frequent deficiencies included: lack of scientific evaluation of the effectiveness of the programme, lack of transparency of cost data, and quality improvement activities. CONCLUSIONS: For the purpose of a nation-wide implementation of disease management programmes the existing patient education programmes in Germany need to be further improved. Single examples demonstrated that the accessible criteria of self-management are not sufficient for the evaluation of already established patient education programmes.

Asthma↗

[Statistical survey on laparoscopy in gynaecology up to 1977 in the Federal Republic of Germany (author's transl)].

1385 questionaires were sent to gynaecologists in West Germany. 682 (49.2%) were answered anonymously. 302 answers (44.2%) revealed that the gynaecologists did not do endoscopy. 265.900 pelviscopies or laparoscopies were included in the statistics. The laparoscopies or pelviscopies were done from 1949--1977 by 380 gynaecologic surgeons or gynaecological departments. In Germany to the end of 1977 unipolar high frequency current was used for hemostasis in 52%, bipolar high frequency current in 42%, and modern endocoaglation in 25% of the departments. In 240 departments (63%) the five to 8 mm. pelviscope was used. In 124 department (33%) the 11 mm. laparoscope was used. In the total of the cases 949 (3.56/1000) complications occurred. These required 690 laparotomies (2.59/1000). The cause of the complications were injuries to vessels or high frequency current burns. A total of 24 (0.09/1000) deaths or 1 death per 11,000 pelviscopies was reported. The operative mortality was 13 deaths (0.09/1000) in 140,977 (53%) purely diagnostic pelviscopies or laparoscopies, 3 deaths (0.08/1000) in 37,639 (14.2%) combined diagnostic and operative pelviscopies and 8 deaths (0.09/1000) in 87,284 (32.8%) laparoscopic tubal ligations. Since 1974 the operative mortality is less than 1:100,000. Since 1973 approximately 30--35,000 pelviscopies are done yearly in West Germany.

Electrocoagulation↗

Therapeutic use, efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS in children with acute sinusitis in Germany.

The therapeutic efficiency and safety of the proteolytic enzyme bromelaine obtained from pineapple (Bromelain-POS, Ursapharm GmbH, Saarbrücken, Germany) was evaluated in children under the age of 11 years diagnosed with acute sinusitis. Data from 116 patients from 19 centres located across Germany were analysed in a pharmacoepidemiological cohort study. Patient cohorts were either treated with Bromelain-POS (N = 62), in combination with Bromelain-POS and standard therapies (N = 34), or with standard therapies (N = 20). The primary parameter measuring effectiveness of the different treatment groups was the duration of symptoms. The shortest mean period of symptoms was observed in patients treated with Bromelain-POS alone (6.66 days), followed by the standard therapy (7.95 days) and those treated with a combination of Bromelain-POS and the standard therapy (9.06 days). Patients of the Bromelain-POS monotherapy group showed a statistically significant faster recovery from symptoms (p = 0.005) compared to the other treatment groups. One 10-year-old male patient, with a known pineapple allergy, showed a self-limiting mild allergic reaction. No other unwanted side-effects were reported. This trial documents that the proteolytic pineapple enzyme Bromelain-POS is widely used in the treatment of young children diagnosed with acute sinusitis in Germany and that the use of proteolytic enzymes can benefit such patients.

Acute Disease↗